📰 Membrane Type News
Membrane Type News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Membrane Type. Real-time updates on events, politics, business and more.
March 12, 2024
/PRNewswire/ -- Industrial Filtration Market is expected to reach USD 47.1 billion by 2029 from USD 37.1 billion in 2024 at a CAGR of 4.9% during the forecast...
February 28, 2024
Deerfield Management Company L.P. Series C bought a new position in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 448,753 shares of the company’s stock, valued at approximately $9,015,000. Deerfield Management Company L.P. Series […]
February 28, 2024
Deerfield Management Company L.P. Series C acquired a new stake in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 448,753 shares of the company’s stock, valued at approximately $9,015,000. Several other hedge funds have also recently added […]
February 24, 2024
Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) released its earnings results on Tuesday. The company reported ($1.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.23) by $0.07, reports. The firm had revenue of $5.33 million during the quarter, compared to the consensus estimate of $11.68 million. Bicycle Therapeutics had a negative […]
February 21, 2024
Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) – Equities research analysts at Leerink Partnrs issued their FY2025 earnings per share estimates for Bicycle Therapeutics in a note issued to investors on Tuesday, February 20th. Leerink Partnrs analyst J. Chang forecasts that the company will earn ($5.20) per share for the year. The consensus estimate for […]
January 31, 2024
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 […]
January 8, 2024
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 […]
January 6, 2024
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) insider Nigel Crockett sold 2,643 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $17.50, for a total value of $46,252.50. Following the completion of the transaction, the insider now directly owns 48,716 shares of […]
January 5, 2024
AtonRa Partners lessened its position in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 18.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,588 shares of the company’s stock after selling 2,631 shares during the period. AtonRa Partners’ holdings in Bicycle Therapeutics were worth […]
January 5, 2024
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) gapped down prior to trading on Friday following insider selling activity. The stock had previously closed at $17.46, but opened at $16.96. Bicycle Therapeutics shares last traded at $16.73, with a volume of 20,461 shares. Specifically, CEO Kevin Lee sold 8,703 shares of the firm’s […]